Product Overview
Compounded Oral Tirzepatide is an oral formulation of a dual GLP-1 and GIP receptor agonist intended to support appetite and metabolic regulation under medical supervision.
How It Works
Tirzepatide activates both GLP-1 and GIP receptors. This dual action supports appetite regulation, insulin secretion, and metabolic balance.
Safety Information
This medication may not be appropriate for all individuals.
Do not use if you have:
- A personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Consult a healthcare provider before use if you have:
- A history of pancreatitis
- Gallbladder disease
- Kidney disease or dehydration
- Liver disease
- Severe gastrointestinal disorders
- Diabetic retinopathy
- Thyroid disease
Delayed gastric emptying may affect the absorption of oral medications.
Common Side Effects
Commonly reported side effects may include:
Nausea
Vomiting
Diarrhea
Constipation
Abdominal discomfort
Decreased appetite
Fatigue
Headache
Dizziness
Serious adverse effects may include pancreatitis, gallbladder complications, kidney injury, or severe gastrointestinal reactions.
Compounding Disclosure
This medication is compounded by a licensed pharmacy and is not FDA-approved. It is prepared based on a healthcare provider’s prescription.